Eisai Co. Ltd.'s Fiscal Year is From April To March.
The item "Ebit-Interest-Coverage" stands at 16.40 as of 09/30/2025, the lowest value since 03/31/2023.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Ebit Interest Coverage" stands at 16.40. This represents a decrease of -9.94 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -3.78 compared to the value the year prior.
The Serie's long term average value is 19.61. It's latest available value, on 09/30/2025, is -3.21 lower, compared to it's long term average value.
The Serie's change from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +17.01 .
The Serie's change from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -16.72 .
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebit Interest Coverage | 905,699,262,464.00 |
![]() | Johnson & Johnson - Ebit Interest Coverage | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebit Interest Coverage | 399,570,305,024.00 |
![]() | Roche Holding AG - Ebit Interest Coverage | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Ebit Interest Coverage | 280,205,508,085.11 |